Glaukos’ Epioxa gains FDA nod for non-invasive keratoconus therapy | Optometry Times - Clinical News
Published on October 20, 2025
The FDA-approved topical cross-linking treatment aims to simplify keratoconus care while improving patient comfort, with availability expected in early 2026.